BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:PUBLISH X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT CLASS:PUBLIC CREATED:20230504T073117Z DESCRIPTION:Pharmaceuticals R&D Event // June 28\, 2023\n \nBayer has been researching and developing innovative medications and new therapeutic appr oaches that help make a difference to people’s lives for more than a cen tury. We are determined to drive breakthrough innovations for patients in diseases of high unmet medical need.\n \nJoin Stefan Oelrich\, President o f the Pharmaceuticals Division and Member of the Board of Management of Ba yer AG\, along with Christian Rommel\, EVP\, Global Head of R&D\, Bayer Ph armaceuticals and his team to get an update and latest insights into our R &D progress and ambitions. \n \nThe event will be held in English.\n \n DTEND;TZID="Eastern Standard Time":20230628T130000 DTSTAMP:20230411T111520Z DTSTART;TZID="Eastern Standard Time":20230628T080000 LAST-MODIFIED:20230504T073117Z LOCATION:Online Livestream PRIORITY:5 SEQUENCE:0 SUMMARY;LANGUAGE=de:Pharmaceuticals R&D Event TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000A05646096D6CD901000000000000000 0100000005D02D33BC6FB284190A9AF29A89D4E22 X-ALT-DESC;FMTTYPE=text/html:

Pharmaceuticals R&\;D Event // June 28\, 2023

 \;

Bayer has been researching and d eveloping innovative medications and new therapeutic approaches that help make a difference to people’s lives for more than a century. We are dete rmined to drive breakthrough innovations for patients in diseases of high unmet medical need.

 \;

Join Stefan Oelr ich\, President of the Pharmaceuticals Division and Member of the Board of Management of Bayer AG\, along with Christian Rommel\, EVP\, Global Head of R&\;D\, Bayer Pharmaceuticals and his team to get an update and late st insights into our R&\;D progress and ambitions.

 \;

The event will be held in English.

 \ ;

X-MICROSOFT-CDO-BUSYSTATUS:BUSY X-MICROSOFT-CDO-IMPORTANCE:1 X-MICROSOFT-DISALLOW-COUNTER:FALSE X-MS-OLK-AUTOFILLLOCATION:FALSE X-MS-OLK-CONFTYPE:0 BEGIN:VALARM TRIGGER:-PT15M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR